Literature DB >> 23202369

Neutrophil proteinase 3 acts on protease-activated receptor-2 to enhance vascular endothelial cell barrier function.

Christopher J Kuckleburg1, Peter J Newman.   

Abstract

OBJECTIVE: The principle role of the vascular endothelium is to present a semi-impermeable barrier to soluble factors and circulating cells, while still permitting the passage of leukocytes from the bloodstream into the tissue. The process of diapedesis involves the selective disruption of endothelial cell junctions, which could compromise vascular integrity. It is therefore somewhat surprising that neutrophil transmigration does not significantly impair endothelial barrier function. We examined whether neutrophils might secrete factors that promote vascular integrity during the latter stages of neutrophil transmigration, in particular, the role of neutrophil serine proteinase 3 (PR3). METHODS AND
RESULTS: Endothelial cells were treated with PR3 either in its soluble form or in a complex form with cell surface NB1. We observed that PR3 mediated the enhancement of endothelial cell junctional integrity and that this required its proteolytic activity, as well as endothelial cell expression of the protease-activated receptor-2. Importantly, PR3 suppressed the vascular permeability changes and disruption of junctional proteins induced by the action of protease-activated receptor-1 agonists.
CONCLUSIONS: These findings establish the potential for neutrophil-derived PR3 to play a role in reestablishing vascular integrity after leukocyte transmigration and in protecting endothelial cells from protease-activated receptor-1-induced permeability changes that occur during thrombotic and inflammatory events.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23202369      PMCID: PMC3562705          DOI: 10.1161/ATVBAHA.112.300474

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  73 in total

1.  ACUTE INFLAMMATION: THE EFFECT OF CONCURRENT LEUCOCYTIC EMIGRATION AND INCREASED PERMEABILITY ON PARTICLE RETENTION BY THE VASCULAR WALL.

Authors:  J V HURLEY
Journal:  Br J Exp Pathol       Date:  1964-12

Review 2.  Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled?

Authors:  Pingnian He
Journal:  Cardiovasc Res       Date:  2010-05-13       Impact factor: 10.787

3.  Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis.

Authors:  A Belaaouaj; R McCarthy; M Baumann; Z Gao; T J Ley; S N Abraham; S D Shapiro
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

Review 4.  Endothelial cells in physiology and in the pathophysiology of vascular disorders.

Authors:  D B Cines; E S Pollak; C A Buck; J Loscalzo; G A Zimmerman; R P McEver; J S Pober; T M Wick; B A Konkle; B S Schwartz; E S Barnathan; K R McCrae; B A Hug; A M Schmidt; D M Stern
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

5.  Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2.

Authors:  W Kong; K McConalogue; L M Khitin; M D Hollenberg; D G Payan; S K Böhm; N W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

6.  Identification of potential activators of proteinase-activated receptor-2.

Authors:  M T Fox; P Harriott; B Walker; S R Stone
Journal:  FEBS Lett       Date:  1997-11-17       Impact factor: 4.124

7.  fMLP-stimulated neutrophils increase endothelial [Ca2+]i and microvessel permeability in the absence of adhesion: role of reactive oxygen species.

Authors:  Longkun Zhu; Vince Castranova; Pingnian He
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-10-21       Impact factor: 4.733

8.  The role of proteinase 3 (PR3) and the protease-activated receptor-2 (PAR-2) pathway in dendritic cell (DC) maturation of human-DC-like monocytes and murine DC.

Authors:  Bo Jiang; Evelin Grage-Griebenow; Elena Csernok; Kristine Butherus; Stefan Ehlers; Wolfgang L Gross; Julia U Holle
Journal:  Clin Exp Rheumatol       Date:  2010 Jan-Feb       Impact factor: 4.473

9.  PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front.

Authors:  G Cepinskas; M Sandig; P R Kvietys
Journal:  J Cell Sci       Date:  1999-06       Impact factor: 5.285

10.  The functional paradox of CD43 in leukocyte recruitment: a study using CD43-deficient mice.

Authors:  R C Woodman; B Johnston; M J Hickey; D Teoh; P Reinhardt; B Y Poon; P Kubes
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

View more
  16 in total

1.  Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells.

Authors:  Disha M Gandhi; Mark W Majewski; Ricardo Rosas; Kaitlin Kentala; Trevor J Foster; Eric Greve; Chris Dockendorff
Journal:  Bioorg Med Chem       Date:  2018-04-06       Impact factor: 3.641

Review 2.  Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.

Authors:  Jie Zhou; Yulia Nefedova; Aihua Lei; Dmitry Gabrilovich
Journal:  Semin Immunol       Date:  2017-12-15       Impact factor: 11.130

Review 3.  PECAM-1: regulator of endothelial junctional integrity.

Authors:  Jamie R Privratsky; Peter J Newman
Journal:  Cell Tissue Res       Date:  2014-01-17       Impact factor: 5.249

4.  PAR2-dependent activation of GSK3β regulates the survival of colon stem/progenitor cells.

Authors:  Imen Nasri; Delphine Bonnet; Bailey Zwarycz; Emilie d'Aldebert; Sokchea Khou; Raoudha Mezghani-Jarraya; Muriel Quaranta; Corinne Rolland; Chrystelle Bonnart; Emmanuel Mas; Audrey Ferrand; Nicolas Cenac; Scott Magness; Laurianne Van Landeghem; Nathalie Vergnolle; Claire Racaud-Sultan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-06-16       Impact factor: 4.052

5.  The Key Factors Predicting Dementia in Individuals With Alzheimer's Disease-Type Pathology.

Authors:  Andrew N McCorkindale; Ellis Patrick; James A Duce; Boris Guennewig; Greg T Sutherland
Journal:  Front Aging Neurosci       Date:  2022-04-25       Impact factor: 5.702

6.  Characterization of a novel mouse model with genetic deletion of CD177.

Authors:  Qing Xie; Julia Klesney-Tait; Kathy Keck; Corey Parlet; Nicholas Borcherding; Ryan Kolb; Wei Li; Lorraine Tygrett; Thomas Waldschmidt; Alicia Olivier; Songhai Chen; Guang-Hui Liu; Xiangrui Li; Weizhou Zhang
Journal:  Protein Cell       Date:  2014-10-31       Impact factor: 14.870

Review 7.  Rheumatic Disease: Protease-Activated Receptor-2 in Synovial Joint Pathobiology.

Authors:  Kendal McCulloch; Sarah McGrath; Carmen Huesa; Lynette Dunning; Gary Litherland; Anne Crilly; Leif Hultin; William R Ferrell; John C Lockhart; Carl S Goodyear
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-23       Impact factor: 5.555

8.  Salivary proteome signatures in the early and middle stages of human pregnancy with term birth outcome.

Authors:  Amit Kumar Dey; Bhoj Kumar; Abhishek Kumar Singh; Prakash Ranjan; Ramachandran Thiruvengadam; Bapu Koundinya Desiraju; Pallavi Kshetrapal; Nitya Wadhwa; Shinjini Bhatnagar; Faraz Rashid; Dipankar Malakar; Dinakar M Salunke; Tushar Kanti Maiti
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

9.  The cardioprotective effects of secretory leukocyte protease inhibitor against myocardial ischemia/reperfusion injury.

Authors:  Eakkapote Prompunt; Jantira Sanit; Stephanie Barrère-Lemaire; Joel Nargeot; Hannah Noordali; Melanie Madhani; Sarawut Kumphune
Journal:  Exp Ther Med       Date:  2018-04-25       Impact factor: 2.447

10.  Intravital imaging with two-photon microscopy reveals cellular dynamics in the ischeamia-reperfused rat heart.

Authors:  Ryohei Matsuura; Shigeru Miyagawa; Satsuki Fukushima; Takasumi Goto; Akima Harada; Yuri Shimozaki; Kazumasa Yamaki; Sho Sanami; Junichi Kikuta; Masaru Ishii; Yoshiki Sawa
Journal:  Sci Rep       Date:  2018-10-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.